The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 05, 2023

Filed:

Dec. 12, 2019
Applicant:

Mitopower, Llc, Palo Alto, CA (US);

Inventors:

Gangadhara Ganapati, Palo Alto, CA (US);

Atignal Shankara Rao Arvind, Bangalore, IN;

Assignee:

MitoPower LLC, Palo Alto, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/70 (2006.01); A01N 43/04 (2006.01); A61K 31/706 (2006.01); A61P 3/10 (2006.01); A61K 31/502 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/706 (2013.01); A61K 31/502 (2013.01); A61K 45/06 (2013.01); A61P 3/10 (2018.01);
Abstract

The disclosure provides nicotinamide riboside (NR), the reduced form of NR (NRH), nicotinic acid riboside (NAR), the reduced form of NAR (NARH), derivatives thereof, compositions thereof and uses thereof. The NR and NAR derivatives have improved stability and bioavailability compared to NR and NAR. NR, NRH, NAR, NARH, and derivatives thereof can increase intracellular NADlevels, and can enhance mitochondrial and cellular function and cell viability. Therefore, NR, NRH, NAR, NARH, and derivatives thereof, whether alone or in combination with one or more additional therapeutic agents (e.g., a PARP inhibitor), are useful for treating mitochondrial diseases, mitochondria-related diseases and conditions, and other disorders and conditions.


Find Patent Forward Citations

Loading…